SomaLogic to Announce Fourth Quarter and Full Year 2022 Financial Results

Rhea-AI Summary

SomaLogic, a leader in proteomics technology, will release its financial results for the fourth quarter and full year of 2022 on March 28, 2023, after market close. A conference call with management will occur at 4:30 p.m. ET to discuss these results. Interested participants can register for the call online and access a live and archived version of the webcast on the company’s investor relations page. SomaLogic focuses on providing actionable health-management information through its SomaScan Platform, aimed at optimizing personal health via protein measurement.

Positive

• Scheduled reporting of 2022 financial results enhances transparency.
• Management will host a conference call for direct communication with investors.

Negative

• None.

BOULDER, Colo., March 09, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that it will report financial results for the fourth quarter and full year 2022 after market close on Tuesday, March 28, 2023. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.

Those interested in listening to the conference call should register online here. Participants are encouraged to register more than 15 minutes before the start of the call. A live and archived version of the webcast will be available at https://investors.somalogic.com/.

About SomaLogic
SomaLogic (Nasdaq: SLGC) seeks to deliver precise, meaningful, and actionable health-management information that empowers individuals worldwide to continuously optimize their personal health and wellness throughout their lives. This essential information, to be provided through a global network of partners and users, is derived from SomaLogic’s personalized measurement of important changes in an individual’s proteins over time. For more information, visit www.somalogic.com and follow @somalogic on Twitter.

The SomaScan Platform is for Research Use Only (RUO) and has not been cleared or approved by the U.S. Food and Drug Administration for diagnostic or patient management purposes.

Investor Contact
Marissa Bych
Gilmartin Group LLC
investors@somalogic.com

SomaLogic Contact
Emilia Costales
720-798-5054
ecostales@somalogic.com

FAQ

When will SomaLogic announce its financial results for 2022?

SomaLogic will announce its financial results for 2022 on March 28, 2023.

What time is the conference call for SomaLogic's financial results?

The conference call will begin at 4:30 p.m. ET on March 28, 2023.

How can I listen to SomaLogic's conference call?

You can register to listen to the conference call online through the investor relations page.

What is the stock symbol for SomaLogic?

The stock symbol for SomaLogic is SLGC.